3626 results for «283»
3626 results
Tricuspid and other structural interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
In this series of submitted cases, explore challenges and bailouts around tricuspid valve intervention and other forms of structural interventions. Learn about a percutaneous solution to acute traumatic pulmonary regurgitation, a rare complication of inadequate sealing caused by anchor slip through the fabric part in a...
Rapid-fire - Complex procedure in TAVI - Part 2
18 Feb 2024 – From PCR Tokyo Valves 2024
In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock, treatment of severe AR after infective endocarditis, and more!
Rapid-fire - Complications of Mitral TEER - Part 2
18 Feb 2024 – From PCR Tokyo Valves 2024
Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the second part of this session rapid-fire submission cases [in Japanese].
A journey with Charles Dotter: his contribution to transluminal angioplasty
In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.
In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
